Insider trading

Period: 120 months Stock: PASG Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

84 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

84 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

84 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

84 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
84 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
84 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

84 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
25 Jun 2026
Lynx1 Capital Management LP 10% owner · indirect
Bought
$206.10K 50,055 at 4.12
8.0%
8 Jan 2026
Chou William PRESIDENT AND CEO
Sold at will
$75.16K 4,076 at 18.44
38.5%
Not planned
8 Jan 2026
Sold at will
$38.02K 2,062 at 18.44
27.6%
Not planned
15 Sep 2025
Lynx1 Capital Management LP 10% owner · indirect
Bought
$83.18K 11,900 at 6.99
1.9%
12 Sep 2025
Lynx1 Capital Management LP 10% owner · indirect
Bought
$138.30K 19,783 at 6.99
3.3%
11 Sep 2025
Lynx1 Capital Management LP 10% owner · indirect
Bought
$2.26K 325 at 6.96
0.1%
24 Jul 2025
Lynx1 Capital Management LP 10% owner · indirect
Bought
$379.45K 66,423 at 5.71
12.6%
Largest buy in 3 yrs
23 Jul 2025
Lynx1 Capital Management LP 10% owner · indirect
Bought
$283.03K 49,302 at 5.74
10.4%
Largest buy in 3 yrs
22 Jul 2025
Lynx1 Capital Management LP 10% owner · indirect
Bought
$71.34K 13,123 at 5.44
2.8%
26 Jun 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$70.37K 213,257 at 0.33
3.4%
Not planned
25 Jun 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$45.80K 138,800 at 0.33
2.2%
Not planned
24 Jun 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$81.06K 231,600 at 0.35
3.5%
Not planned
24 Apr 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$21.82K 68,195 at 0.32
1.0%
Not planned
23 Apr 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$30.37K 89,328 at 0.34
1.3%
Not planned
22 Apr 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$26.54K 78,049 at 0.34
1.1%
Not planned
17 Apr 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$25.44K 77,090 at 0.33
1.1%
Not planned
16 Apr 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$20.34K 61,638 at 0.33
0.9%
Not planned
15 Apr 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$3.92K 10,326 at 0.38
0.1%
Not planned
11 Feb 2025
Sold at will
$1.69K 3,183 at 0.53
7.2%
Not planned
14 Jan 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$47.41K 79,024 at 0.60
1.1%
Not planned
13 Jan 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$11.51K 17,986 at 0.64
0.3%
Not planned
10 Jan 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$83.30K 126,209 at 0.66
1.7%
Not planned
8 Jan 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$51.00K 75,007 at 0.68
1.0%
Not planned
7 Jan 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$37.30K 52,536 at 0.71
0.7%
Not planned
6 Jan 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$15.00K 19,481 at 0.77
0.3%
Not planned
27 Dec 2024
Lynx1 Capital Management LP 10% owner · indirect
Bought
$241.04K 373,645 at 0.65
4.2%
Largest buy in 3 yrs
20 Dec 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$138.19K 230,321 at 0.60
3.0%
Not planned
11 Dec 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$64.00 80 at 0.80
0.0%
Not planned
10 Dec 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$6.41K 8,015 at 0.80
0.1%
Not planned
9 Dec 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$45.51K 54,181 at 0.84
0.7%
Not planned
6 Dec 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$17.14K 20,903 at 0.82
0.3%
Not planned
4 Dec 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$60.20K 76,200 at 0.79
1.0%
Not planned
27 Nov 2024
Lynx1 Capital Management LP 10% owner · indirect
Bought
$19.66K 29,300 at 0.67
0.3%
26 Nov 2024
Lynx1 Capital Management LP 10% owner · indirect
Bought
$118.19K 167,055 at 0.71
1.9%
25 Nov 2024
Lynx1 Capital Management LP 10% owner · indirect
Bought
$146.66K 259,998 at 0.56
3.1%
First buy on file
19 Sep 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$27.90K 39,300 at 0.71
0.5%
Not planned
18 Sep 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$18.71K 25,631 at 0.73
0.3%
Not planned
17 Sep 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$81.32K 111,400 at 0.73
1.4%
Not planned
16 Sep 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$46.69K 63,100 at 0.74
0.8%
Not planned
13 Feb 2024
Forman Mark S CHIEF MEDICAL OFFICER
Sold at will
$1.59K 1,638 at 0.97
3.3%
Not planned
13 Feb 2024
Borthwick Kathleen SVP, INTERIM CFO
Sold at will
$1.43K 1,470 at 0.97
4.9%
Not planned
2 Jan 2024
Forman Mark S Chief Medical Officer
Sold at will
$14.39K 15,813 at 0.91
25.9%
Not planned
2 Jan 2024
Cale Edgar B. GC & Corporate Secretary
Sold at will
$14.39K 15,813 at 0.91
25.6%
Not planned
2 Jan 2024
Borthwick Kathleen SVP, Interim CFO
Sold at will
$9.71K 10,672 at 0.91
29.2%
Not planned
28 Jul 2023
King Simona Chief Financial Officer
Sold at will
$10.08K 11,453 at 0.88
32.3%
Not planned
28 Jun 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Bought
$483.16K 575,195 at 0.84
7.7%
27 Jun 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Bought
$518.60K 617,382 at 0.84
9.0%
16 Jun 2023
Fotopoulos Alexandros Chief Technical Officer
Sold at will
$3.78K 4,052 at 0.93
12.4%
Not planned
18 Apr 2023
King Simona Chief Financial Officer
Sold at will
$2.16K 2,053 at 1.05
50.0%
Sold half or more
1 Dec 2022
Kapadia Sandip Director
Sold, plan not stated
$5.96K 5,000 at 1.19
100%
Sold half or more
Showing 1–50 of 84. Page 1 of 2 Older →